|Home||» Products||» Pharmaceutical Products||» KEYTRUDA 50 mg|
KEYTRUDA 50 mg
- Minimum Order Quantity
- Unit of Measure
- Payment Terms
- Letter of Credit (L/C), Others
- Packaging Details
- in carton boxes.
- Main Export Market(s)
- Asia, Eastern Europe, Western Europe, Africa
PLEASE CONTACT US FOR FURTHER DETAILS
KEYTRUDA 50 Mg Powder for concentrate for solution for infusion
One vial of powder contains 50 mg of pembrolizumab.
After reconstitution, 1 ml of concentrate contains 25 mg of pembrolizumab.
Pembrolizumab is a humanised monoclonal anti-programmed cell death-1 (PD-1) antibody (IgG4/kappa isotype with a stabilising sequence alteration in the Fc region) produced in Chinese hamster ovary cells by recombinant DNA technology.
Powder for concentrate for solution for infusion.
White to off-white lyophilised powder.
List of excipients
L-histidine hydrochloride monohydrate